Estradiol as an anti-aromatase agent in human breast cancer cells

Journal of Steroid Biochemistry and Molecular Biology

Volumn 98, Issue 1, 2006, Pages 12-17

  Pasqualini, J R ^a   Chetrite, G S ^a,b  

^a Institut de Puericulture   (France)

^b BICÊTRE HOSPITAL   (France)

Author keywords

Anti aromatase; Breast cancer; Estradiol

Indexed keywords

AROMATASE; AROMATASE INHIBITOR; DNA; ESTRADIOL; ESTRONE; STEROID; TESTOSTERONE; TESTOSTERONE 17BETA DEHYDROGENASE; TRITIUM;

ARTICLE; BREAST CANCER; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME SYNTHESIS; HUMAN; HUMAN CELL; IC 50; RADIOACTIVITY; THIN LAYER CHROMATOGRAPHY;

AROMATASE; AROMATASE INHIBITORS; BREAST NEOPLASMS; CHROMATOGRAPHY, THIN LAYER; DNA, COMPLEMENTARY; ESTRADIOL; ESTRONE; HUMANS; NEOPLASMS, HORMONE-DEPENDENT; STEROIDS; SULFATASES; TESTOSTERONE; TRANSFECTION; TUMOR CELLS, CULTURED;

MINK CELL FOCUS-FORMING VIRUS;

EID: 30944450389     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2005.10.001     Document Type: Article

References (41)

1. A. Segaloff Hormones and mammary carcinogenesis W.L. McGuire Breast Cancer 2: Advances in Research and Treatment 1978 Plenum Press New York 1 22
2. M.A. Kirschner The role of hormones in the development of human breast cancer W.L. McGuire Breast Cancer 3: Advances in Research and Treatment, Current Topics 1979 Plenum Press New York 199 226
3. B.E. Henderson, R. Ross, and L. Bernstein Estrogens as a cause of human cancer: the Richard and Hinda Rosenthal Foundation Award Lecture Cancer Res. 48 1988 246 253
4. Y.J. Abul-Hajj, R. Iverson, and D.T. Kiang Aromatization of androgens by human breast cancer Steroids 33 1979 205 222
5. A. Lipton, S.J. Santner, R.J. Santen, H.A. Harvey, P.D. Feil, D. White-Hershey, M.J. Bartholomew, and C.E. Antle Aromatase activity in primary and metastatic human breast cancer Cancer 59 1987 779 782
6. A.S. Bhatnagar, C. Batzl, A. Häusler, K. Schieweck, M. Lang, and P.F. Trunet Pharmacology of nonsteroidal aromatase inhibitors J.R. Pasqualini B.S. Katzenellenbogen Hormone-dependent Cancer 1996 Marcel Dekker New York 155 168
7. T.L. Dao, C. Hayes, and P.R. Libby Steroid sulfatase activities in human breast tumors Proc. Soc. Expl. Biol. Med. 146 1974 381 384
8. F. Vignon, M. Terqui, B. Westley, D. Derocq, and H. Rochefort Effects of plasma estrogen sulfates in mammary cancer cells Endocrinology 106 1980 1079 1086
9. J.R. Pasqualini, C. Gelly, and F. Lecerf Estrogen sulfates: biological and ultrastructural responses and metabolism in MCF-7 human breast cancer cells Breast Cancer Res. Treat. 8 1986 233 240
10. J.R. MacIndoe with the technical assistance of G. Woods, L. Jeffries, M. Hinkhouse, The hydrolysis of estrone sulfate and dehydroepiandrosterone sulfate by MCF-7 human breast cancer cells, Endocrinology 123 (1988) 1281-1287.
11. J.R. Pasqualini, C. Gelly, B.-L. Nguyen, and C. Vella Importance of estrogen sulfates in breast cancer J. Steroid Biochem. 34 1989 155 163
12. R.C. Bonney, M.J. Reed, K. Davidson, P.A. Beranek, and V.H.T. James The relationship between 17β-hydroxysteroid dehydrogenase activity and oestrogen concentrations in human breast tumours and in normal breast tissue Clin. Endocr. 19 1983 727 739
13. 3H-œstradiol by normal breast and breast tumour tissues in post-menopausal women Int. J. Cancer 38 1986 193 196
14. B.-L. Nguyen, G. Chetrite, and J.R. Pasqualini Transformation of estrone and estradiol in hormone-dependent and hormone-independent human breast cancer cells. Effects of the antiestrogen ICI 164,384, danazol, and promegestone (R-5020) Breast Cancer Res. Treat. 34 1995 139 146
15. J.R. Pasqualini, G. Chetrite, C. Blacker, M.-C. Feinstein, L. Delalonde, M. Talbi, and C. Maloche Concentrations of estrone, estradiol, and estrone sulfate and evaluation of sulfatase and aromatase activities in pre- and postmenopausal breast cancer J. Clin. Endocrinol. Metab. 81 1996 1460 1464
16. S.J. Santner, P.D. Feil, and R.J. Santen In situ estrogen production via the estrone sulfatase pathway in breast tumors: relative importance versus the aromatase pathway J. Clin. Endocr. Metab. 59 1984 29 33
17. J.R. Pasqualini Steroid sulphotransferase activity in human hormone-independent MDA-MB-468 mammary cancer cells Eur. J. Cancer 28A 1992 758 762
18. J.L. Falany, and C.N. Falany Expression of cytosolic sulfotransferases in normal mammary epithelial cells and breast cancer cell lines Cancer Res. 56 1996 1551 1555
19. A.M.H. Brodie, L.Y. Wing, M. Dowsett, and R.C. Coombes Aromatase inhibitors and treatment of breast cancer J. Steroid Biochem. 24 1986 91 97
20. P.C. de Jong, J. van de Ven, H.W.R. Nortier, I. Maitimu-Smeele, T.H. Donker, J.H.H. Thijssen, P.H.T.J. Slee, and R.A. Blankenstein Inhibition of breast cancer tissue aromatase activity and estrogen concentrations by the third-generation aromatase inhibitor Vorozole Cancer Res. 57 1997 2109 2111
21. X.-Z. Sun, D. Zhou, and S. Chen Autocrine and paracrine actions of breast tumor aromatase. A three-dimensional cell culture study involving aromatase transfected MCF-7 and T-47D cells J. Steroid Biochem. Mol. Biol. 63 1997 29 36
22. K. Burton A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid Biochem. J. 62 1956 315 323
23. J.R. Pasqualini, and G. Chetrite Paradoxical effect of estradiol: it can block its own bioformation in human breast cancer cells J. Steroid Biochem. Mol. Biol. 78 2001 21 24
24. W.R. Miller, and J. Jackson The therapeutic potential of aromatase inhibitors Expert Opin. Investig. Drugs 12 2003 337 351
25. A. Brodie M. Dowsett N. Harada P. Lonning W.R. Miller J.R. Pasqualini R. Santen H. Sasano E. Simpson 'Aromatase 2002' Proceedings of the VI International Aromatase Conference Kyoto, Japan, October 26-30 2002 J. Steroid Biochem. Mol. Biol. 86 2003 217 507
26. W.R. Miller, T.J. Anderson, S. White, A. Larionov, J. Murray, D. Evans, A. Krause, and J.M. Dixon Aromatase inhibitors: cellular and molecular effects J. Steroid Biochem. Mol. Biol. 95 2005 83 89
27. V.N. Kristensen, T. Sorlie, J. Geisler, N. Yoshimura, O.-C. Linegjaerde, I. Glad, A. Frigessi, N. Harada, P.E. Lonning, and A.-L. Borresen-Dale Effects of anastrozole on the intratumoral gene expression in locally advanced breast cancer J. Steroid Biochem. Mol. Biol. 95 2005 105 111
28. J.N. Ingle, and V.J. Suman Aromatase inhibitors for therapy of advanced breast cancer J. Steroid Biochem. Mol. Biol. 95 2005 113 119
29. R.W. Brueggemeier, E.S. Diaz-Cruz, P.-K. Li, Y. Sugimoto, Y.C. Lin, and C.L. Shapiro Translational studies on aromatase, cyclooxygenases, and enzyme inhibitors in breast cancer J. Steroid Biochem. Mol. Biol. 95 2005 129 136
30. S.R.D. Johnston, L.-A. Martin, J. Head, I. Smith, and M. Dowsett Aromatase inhibitors: combinations with fulvestrant and signal transduction inhibitors as a strategy to overcome endocrine resistance J. Steroid Biochem. Mol. Biol. 95 2005 173 181
31. W. Yue, L.M. Berstein, J.-P. Wang, G.M. Clark, C.J. Hamilton, L.M. Demers, and R.J. Santen The potential role of estrogen in aromatase regulation in the breast J. Steroid Biochem. Molec. Biol. 79 2001 157 164
32. D.M. Strickland, R.D. Gambrell, C.A. Butzin, and K. Strickland The relationship between breast cancer survival and prior postmenopausal estrogen use Obstet. Gynaecol. 80 1992 400 404
33. D.B. Willis, E.E. Calle, H.L. Miracle-McMahill, and C.W. Heath Jr. Estrogen replacement therapy and risk of fatal breast cancer in a prospective cohort of postmenopausal women in the United States Cancer Causes Control 7 1996 449 457
34. I. Persson, J. Yuen, L. Bergvist, and C. Schairer Cancer incidence and mortality in women receiving estrogen and estrogen-progestin replacement therapy - long-term follow-up of a Swedish cohort Int. J. Cancer 67 1996 327 332
35. P. Bonnier, F. Bessenay, A.J. Sasco, B. Beedassy, C. Lejeune, S. Romain, C. Charpin, L. Piana, and P.M. Martin Impact of menopausal hormone-replacement therapy on clinical and laboratory characteristics of breast cancer Int. J. Cancer 79 1998 278 282
36. H. Jernström, J. Frenander, M. Fernö, and H. Olsson Hormone replacement therapy before breast cancer diagnosis significantly reduces the overall death rate compared with never-use among 984 breast cancer patients Br. J. Cancer 80 1999 1453 1458
37. H.P. Schneider, and C. Jackisch Potential benefits of estrogens and progestogens on breast cancer Int. J. Fertil. Womens Med. 43 1998 278 285
38. A.A.J. van Landeghem, J. Poortman, M. Nabuurs, and J.H.H. Thijssen Endogenous concentration and subcellular distribution of androgens in normal and malignant human breast tissue Cancer Res. 45 1985 2907 2912
39. J.H.H. Thijssen, J. Daroszewski, A. Milewicz, and M.A. Blankenstein Local aromatase activity in human breast tissue J. Steroid Biochem. Mol. Biol. 44 1993 577 582
40. E. Simpson, M. Jones, M. Misso, K. Hewitt, R. Hill, L. Maffei, C. Carani, and W.C. Boon Estrogen, a fundamental player in energy homeostasis J. Steroid Biochem. Mol. Biol. 95 2005 3 8
41. G.S. Chetrite, J. Cortes-Prieto, J.C. Philippe, F. Wright, and J.R. Pasqualini Comparison of estrogen concentrations, estrone sulfatase and aromatase activities in normal, and in cancerous, human breast tissues J. Steroid Biochem. Mol. Biol. 72 2000 23 27